Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Replicative oncolytic herpes simplex viruses in combination cancer therapies.

Post DE, Fulci G, Chiocca EA, Van Meir EG. Replicative oncolytic herpes simplex viruses in combination cancer therapies. Curr Gene Ther. 2004 Mar; 4(1):41-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.